Order Article Reprints

El-Mrabet A, Diane A, Haloui R, El Monfalouti H, S. Alanazi A, Hefnawy M, Alanazi MM, Kandri-Rodi Y, Elkhattabi S, Mazzah A, et al. Hybrid 2-Quinolone–1,2,3-triazole Compounds: Rational Design, In Silico Optimization, Synthesis, Characterization, and Antibacterial Evaluation. Antibiotics. 2025; 14(9):877. https://doi.org/10.3390/antibiotics14090877

El-Mrabet, Ayoub, Abderrahim Diane, Rachid Haloui, Hanae El Monfalouti, Ashwag S. Alanazi, Mohamed Hefnawy, Mohammed M. Alanazi, Youssef Kandri-Rodi, Souad Elkhattabi, Ahmed Mazzah, and et al. 2025. "Hybrid 2-Quinolone–1,2,3-triazole Compounds: Rational Design, In Silico Optimization, Synthesis, Characterization, and Antibacterial Evaluation" Antibiotics 14, no. 9: 877. https://doi.org/10.3390/antibiotics14090877

El-Mrabet, A., Diane, A., Haloui, R., El Monfalouti, H., S. Alanazi, A., Hefnawy, M., Alanazi, M. M., Kandri-Rodi, Y., Elkhattabi, S., Mazzah, A., Haoudi, A., & Kheira Sebbar, N. (2025). Hybrid 2-Quinolone–1,2,3-triazole Compounds: Rational Design, In Silico Optimization, Synthesis, Characterization, and Antibacterial Evaluation. Antibiotics, 14(9), 877. https://doi.org/10.3390/antibiotics14090877